Symbol:
Clstn2
Name:
calsyntenin 2
RGD ID:
621151
Description:
Predicted to enable calcium ion binding activity. Predicted to be involved in several processes, including associative learning; inhibitory synapse assembly; and positive regulation of synapse assembly. Located in postsynaptic membrane. Orthologous to human CLSTN2 (calsyntenin 2); INTERACTS WITH 17beta-estradiol; 6-propyl-2-thiouracil; atrazine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
alc-gamma; alcadein-gamma; calsyntenin-2; Cs2; Cstn2; LOC100359585
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CLSTN2 (calsyntenin 2)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Mus musculus (house mouse):
Clstn2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Clstn2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CLSTN2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CLSTN2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Clstn2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CLSTN2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CLSTN2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Clstn2 (calsyntenin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
CLSTN1 (calsyntenin 1)
HGNC
OrthoDB
Alliance orthologs 3
Mus musculus (house mouse):
Clstn2 (calsyntenin 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
CLSTN2 (calsyntenin 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
si:ch211-276c2.2
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
clstn2 (calsyntenin 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Cals
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
casy-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
clstn2
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 106,899,894 - 107,516,402 (-) NCBI GRCr8 mRatBN7.2 8 98,020,406 - 98,637,232 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 98,021,666 - 98,637,731 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 103,694,012 - 104,302,007 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 101,893,277 - 102,501,280 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 99,732,207 - 100,340,217 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 105,322,577 - 106,036,821 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 105,323,837 - 105,462,168 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 104,768,386 - 104,906,597 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 102,614,117 - 103,214,037 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 102,633,571 - 103,233,492 (-) NCBI Celera 8 97,454,425 - 98,063,036 (-) NCBI Celera Cytogenetic Map 8 q31 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Clstn2 Rat 1,2-dichloroethane decreases expression ISO RGD:732701 6480464 ethylene dichloride results in decreased expression of CLSTN2 mRNA CTD PMID:28960355 Clstn2 Rat 1,2-dimethylhydrazine increases expression ISO RGD:732701 6480464 1,2-Dimethylhydrazine results in increased expression of CLSTN2 mRNA CTD PMID:22206623 Clstn2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CLSTN2 mRNA CTD PMID:20068009 Clstn2 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CLSTN2 mRNA CTD PMID:17010207 Clstn2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732701 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of CLSTN2 gene CTD PMID:21212295 Clstn2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases methylation ISO RGD:732701 6480464 Tetrachlorodibenzodioxin results in decreased methylation of CLSTN2 gene CTD PMID:21212295 Clstn2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1350123 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CLSTN2 mRNA CTD PMID:26705709 Clstn2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1350123 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Clstn2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO RGD:732701 6480464 4,4'-diaminodiphenylmethane results in decreased expression of CLSTN2 mRNA CTD PMID:18648102 Clstn2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CLSTN2 mRNA CTD PMID:24780913 Clstn2 Rat aflatoxin B1 decreases methylation ISO RGD:1350123 6480464 Aflatoxin B1 results in decreased methylation of CLSTN2 gene CTD PMID:27153756 Clstn2 Rat aflatoxin B1 increases methylation ISO RGD:1350123 6480464 Aflatoxin B1 results in increased methylation of CLSTN2 exon CTD PMID:30157460 Clstn2 Rat aristolochic acid A decreases expression ISO RGD:1350123 6480464 aristolochic acid I results in decreased expression of CLSTN2 mRNA CTD PMID:33212167 Clstn2 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CLSTN2 gene CTD PMID:35440735 Clstn2 Rat benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CLSTN2 mRNA CTD PMID:21839799 Clstn2 Rat benzo[a]pyrene increases methylation ISO RGD:732701 6480464 Benzo(a)pyrene results in increased methylation of CLSTN2 intron CTD PMID:27901495 Clstn2 Rat benzo[a]pyrene increases methylation ISO RGD:1350123 6480464 Benzo(a)pyrene results in increased methylation of CLSTN2 exon; Benzo(a)pyrene results in increased methylation of CLSTN2 more ... CTD PMID:27901495 Clstn2 Rat benzo[a]pyrene multiple interactions ISO RGD:732701 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Clstn2 Rat benzo[b]fluoranthene multiple interactions ISO RGD:732701 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Clstn2 Rat benzo[e]pyrene increases methylation ISO RGD:1350123 6480464 benzo(e)pyrene results in increased methylation of CLSTN2 exon CTD PMID:30157460 Clstn2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732701 6480464 Diethylhexyl Phthalate results in decreased expression of CLSTN2 mRNA CTD PMID:34319233 Clstn2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLSTN2 mRNA CTD PMID:25181051 Clstn2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CLSTN2 mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998 Clstn2 Rat bisphenol A increases expression ISO RGD:732701 6480464 bisphenol A results in increased expression of CLSTN2 mRNA CTD PMID:30951980 Clstn2 Rat bisphenol A multiple interactions ISO RGD:1350123 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Clstn2 Rat cadmium dichloride increases expression ISO RGD:1350123 6480464 Cadmium Chloride results in increased expression of CLSTN2 mRNA CTD PMID:38568856 Clstn2 Rat cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CLSTN2 mRNA CTD PMID:18500788 Clstn2 Rat CGP 52608 multiple interactions ISO RGD:1350123 6480464 CGP 52608 promotes the reaction [RORA protein binds to CLSTN2 gene] CTD PMID:28238834 Clstn2 Rat chlorpyrifos decreases expression ISO RGD:732701 6480464 Chlorpyrifos results in decreased expression of CLSTN2 mRNA CTD PMID:37019170 Clstn2 Rat chrysene multiple interactions ISO RGD:732701 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Clstn2 Rat crocidolite asbestos decreases expression ISO RGD:732701 6480464 Asbestos, Crocidolite results in decreased expression of CLSTN2 mRNA CTD PMID:29279043 Clstn2 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CLSTN2 mRNA CTD PMID:26577399 Clstn2 Rat DDT decreases expression EXP 6480464 DDT results in decreased expression of CLSTN2 mRNA CTD PMID:30207508 Clstn2 Rat dexamethasone multiple interactions ISO RGD:1350123 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Clstn2 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CLSTN2 mRNA CTD PMID:17010207 Clstn2 Rat diquat decreases expression ISO RGD:732701 6480464 Diquat results in decreased expression of CLSTN2 mRNA CTD PMID:36851058 Clstn2 Rat dorsomorphin multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Clstn2 Rat doxorubicin decreases expression ISO RGD:1350123 6480464 Doxorubicin results in decreased expression of CLSTN2 mRNA CTD PMID:29803840 Clstn2 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CLSTN2 mRNA CTD PMID:29391264 Clstn2 Rat ethanol affects splicing ISO RGD:732701 6480464 Ethanol affects the splicing of CLSTN2 mRNA CTD PMID:30319688 Clstn2 Rat ethanol increases expression ISO RGD:732701 6480464 Ethanol results in increased expression of CLSTN2 mRNA CTD PMID:30319688 Clstn2 Rat fentanyl affects expression EXP 6480464 Fentanyl affects the expression of CLSTN2 mRNA CTD PMID:36032789 Clstn2 Rat fonofos increases methylation ISO RGD:1350123 6480464 Fonofos results in increased methylation of CLSTN2 promoter CTD PMID:22847954 Clstn2 Rat formaldehyde increases expression ISO RGD:1350123 6480464 Formaldehyde results in increased expression of CLSTN2 mRNA CTD PMID:28937961 Clstn2 Rat glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of CLSTN2 gene CTD PMID:35440735 Clstn2 Rat GW 4064 decreases expression ISO RGD:732701 6480464 GW 4064 results in decreased expression of CLSTN2 mRNA CTD PMID:26655953 Clstn2 Rat indometacin multiple interactions ISO RGD:1350123 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Clstn2 Rat lead(0) affects expression ISO RGD:1350123 6480464 Lead affects the expression of CLSTN2 mRNA CTD PMID:28903495 Clstn2 Rat lipopolysaccharide decreases methylation ISO RGD:732701 6480464 Lipopolysaccharides results in decreased methylation of CLSTN2 gene CTD PMID:21212295 Clstn2 Rat lipopolysaccharide multiple interactions ISO RGD:732701 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of CLSTN2 gene CTD PMID:21212295 Clstn2 Rat methapyrilene increases methylation ISO RGD:1350123 6480464 Methapyrilene results in increased methylation of CLSTN2 exon CTD PMID:30157460 Clstn2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CLSTN2 gene CTD PMID:35440735 Clstn2 Rat methylmercury chloride increases expression ISO RGD:1350123 6480464 methylmercuric chloride results in increased expression of CLSTN2 mRNA CTD PMID:28001369 Clstn2 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of CLSTN2 mRNA CTD PMID:21515302 Clstn2 Rat N-methyl-4-phenylpyridinium decreases expression ISO RGD:1350123 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CLSTN2 mRNA CTD PMID:24810058 Clstn2 Rat N-methylformamide increases expression ISO RGD:732701 6480464 methylformamide analog results in increased expression of CLSTN2 mRNA; methylformamide results in increased expression of more ... CTD PMID:17040096 Clstn2 Rat nickel atom decreases expression ISO RGD:1350123 6480464 Nickel results in decreased expression of CLSTN2 mRNA CTD PMID:25583101 Clstn2 Rat okadaic acid decreases expression ISO RGD:1350123 6480464 Okadaic Acid results in decreased expression of CLSTN2 mRNA CTD PMID:38832940 Clstn2 Rat ozone multiple interactions ISO RGD:732701 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:27106289|PMID:34911549 Clstn2 Rat panobinostat multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Clstn2 Rat panobinostat increases expression ISO RGD:1350123 6480464 panobinostat results in increased expression of CLSTN2 mRNA CTD PMID:26272509 Clstn2 Rat parathion increases methylation ISO RGD:1350123 6480464 Parathion results in increased methylation of CLSTN2 promoter CTD PMID:22847954 Clstn2 Rat phenobarbital affects methylation ISO RGD:732701 6480464 Phenobarbital affects the methylation of CLSTN2 gene CTD PMID:19233941 Clstn2 Rat phenylmercury acetate multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Clstn2 Rat pirinixic acid decreases expression ISO RGD:732701 6480464 pirinixic acid results in decreased expression of CLSTN2 mRNA CTD PMID:20813756 Clstn2 Rat progesterone increases expression EXP 6480464 Progesterone results in increased expression of CLSTN2 mRNA CTD PMID:20726854 Clstn2 Rat progesterone increases expression ISO RGD:732701 6480464 Progesterone results in increased expression of CLSTN2 mRNA CTD PMID:22238285 Clstn2 Rat SB 431542 multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Clstn2 Rat silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of CLSTN2 mRNA CTD PMID:34779285 Clstn2 Rat sodium arsenite affects methylation ISO RGD:1350123 6480464 sodium arsenite affects the methylation of CLSTN2 gene CTD PMID:28589171 Clstn2 Rat sodium arsenite increases expression ISO RGD:1350123 6480464 sodium arsenite results in increased expression of CLSTN2 mRNA CTD PMID:29301061 Clstn2 Rat sulforaphane decreases expression ISO RGD:732701 6480464 sulforaphane results in decreased expression of CLSTN2 mRNA CTD PMID:30529165 Clstn2 Rat terbufos increases methylation ISO RGD:1350123 6480464 terbufos results in increased methylation of CLSTN2 promoter CTD PMID:22847954 Clstn2 Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CLSTN2 mRNA CTD PMID:21515302 Clstn2 Rat tetraphene multiple interactions ISO RGD:732701 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Clstn2 Rat titanium dioxide affects expression ISO RGD:732701 6480464 titanium dioxide affects the expression of CLSTN2 mRNA CTD PMID:23557971 Clstn2 Rat titanium dioxide decreases methylation ISO RGD:732701 6480464 titanium dioxide results in decreased methylation of CLSTN2 gene CTD PMID:35295148 Clstn2 Rat titanium dioxide increases methylation ISO RGD:732701 6480464 titanium dioxide results in increased methylation of CLSTN2 promoter CTD PMID:35295148 Clstn2 Rat titanium dioxide decreases expression ISO RGD:732701 6480464 titanium dioxide results in decreased expression of CLSTN2 mRNA CTD PMID:29264374 Clstn2 Rat tremolite asbestos decreases expression ISO RGD:732701 6480464 tremolite results in decreased expression of CLSTN2 mRNA CTD PMID:29279043 Clstn2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CLSTN2 mRNA CTD PMID:33387578 Clstn2 Rat trichostatin A increases expression ISO RGD:1350123 6480464 trichostatin A results in increased expression of CLSTN2 mRNA CTD PMID:26272509 Clstn2 Rat trichostatin A multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Clstn2 Rat triclosan increases expression ISO RGD:1350123 6480464 Triclosan results in increased expression of CLSTN2 mRNA CTD PMID:30510588 Clstn2 Rat troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CLSTN2 mRNA CTD PMID:21515302 Clstn2 Rat valproic acid affects expression ISO RGD:1350123 6480464 Valproic Acid affects the expression of CLSTN2 mRNA CTD PMID:25979313 Clstn2 Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CLSTN2 mRNA CTD PMID:29427782 Clstn2 Rat valproic acid multiple interactions ISO RGD:1350123 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Clstn2 Rat valproic acid increases expression ISO RGD:1350123 6480464 Valproic Acid results in increased expression of CLSTN2 mRNA CTD PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369 Clstn2 Rat venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of CLSTN2 mRNA CTD PMID:25423262 Clstn2 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CLSTN2 mRNA CTD PMID:19015723
1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-diaminodiphenylmethane (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) aristolochic acid A (ISO) atrazine (EXP) benzo[a]pyrene (EXP,ISO) benzo[b]fluoranthene (ISO) benzo[e]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium dichloride (ISO) cefaloridine (EXP) CGP 52608 (ISO) chlorpyrifos (ISO) chrysene (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) DDT (EXP) dexamethasone (ISO) diethylstilbestrol (EXP) diquat (ISO) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) ethanol (ISO) fentanyl (EXP) fonofos (ISO) formaldehyde (ISO) glyphosate (EXP) GW 4064 (ISO) indometacin (ISO) lead(0) (ISO) lipopolysaccharide (ISO) methapyrilene (ISO) methoxychlor (EXP) methylmercury chloride (ISO) Muraglitazar (EXP) N-methyl-4-phenylpyridinium (ISO) N-methylformamide (ISO) nickel atom (ISO) okadaic acid (ISO) ozone (ISO) panobinostat (ISO) parathion (ISO) phenobarbital (ISO) phenylmercury acetate (ISO) pirinixic acid (ISO) progesterone (EXP,ISO) SB 431542 (ISO) silicon dioxide (EXP) sodium arsenite (ISO) sulforaphane (ISO) terbufos (ISO) Tesaglitazar (EXP) tetraphene (ISO) titanium dioxide (ISO) tremolite asbestos (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) troglitazone (EXP) valproic acid (EXP,ISO) venlafaxine hydrochloride (EXP) vinclozolin (EXP)
Clstn2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 106,899,894 - 107,516,402 (-) NCBI GRCr8 mRatBN7.2 8 98,020,406 - 98,637,232 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 98,021,666 - 98,637,731 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 103,694,012 - 104,302,007 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 101,893,277 - 102,501,280 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 99,732,207 - 100,340,217 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 105,322,577 - 106,036,821 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 105,323,837 - 105,462,168 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 104,768,386 - 104,906,597 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 102,614,117 - 103,214,037 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 102,633,571 - 103,233,492 (-) NCBI Celera 8 97,454,425 - 98,063,036 (-) NCBI Celera Cytogenetic Map 8 q31 NCBI
CLSTN2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 139,935,185 - 140,577,397 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 139,935,185 - 140,577,397 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 139,654,027 - 140,296,239 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 141,136,897 - 141,769,328 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 141,136,904 - 141,769,328 NCBI Celera 3 138,076,932 - 138,710,571 (+) NCBI Celera Cytogenetic Map 3 q23 NCBI HuRef 3 137,029,438 - 137,660,865 (+) NCBI HuRef CHM1_1 3 139,617,396 - 140,250,542 (+) NCBI CHM1_1 T2T-CHM13v2.0 3 142,682,539 - 143,324,729 (+) NCBI T2T-CHM13v2.0
Clstn2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 97,326,448 - 97,915,433 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 97,326,448 - 97,915,234 (-) Ensembl GRCm39 Ensembl GRCm38 9 97,444,395 - 98,033,373 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 97,444,395 - 98,033,181 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 97,344,814 - 97,933,586 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 97,253,747 - 97,842,519 (-) NCBI MGSCv36 mm8 Celera 9 96,998,129 - 97,587,251 (-) NCBI Celera Cytogenetic Map 9 E3.3 NCBI cM Map 9 51.06 NCBI
Clstn2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955508 5,074,466 - 5,655,884 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955508 5,069,872 - 5,656,621 (-) NCBI ChiLan1.0 ChiLan1.0
CLSTN2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 137,848,569 - 138,489,242 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 137,853,291 - 138,493,972 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 136,971,615 - 137,612,365 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 144,571,574 - 145,201,588 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 144,571,706 - 145,199,768 (+) Ensembl panpan1.1 panPan2
CLSTN2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 23 36,029,356 - 36,645,614 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 23 36,029,371 - 36,635,571 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 23 36,142,872 - 36,639,373 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 23 36,693,005 - 37,166,674 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 23 36,566,381 - 37,166,639 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 23 36,374,497 - 36,857,999 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 23 36,448,350 - 36,932,034 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 23 36,690,788 - 37,174,298 (+) NCBI UU_Cfam_GSD_1.0
Clstn2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 75,254,295 - 75,835,456 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936540 1,994,986 - 2,574,069 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936540 1,994,078 - 2,569,224 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CLSTN2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 80,789,195 - 81,450,657 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 80,789,239 - 81,461,348 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 89,148,892 - 89,296,794 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CLSTN2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 15 49,996,144 - 50,622,454 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 15 49,999,908 - 50,151,120 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 22,955,556 - 23,588,228 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Clstn2 (Heterocephalus glaber - naked mole-rat)
.
Assembly: mRatBN7.2
Assembly: Rnor_6.0
Predicted Target Of
Count of predictions: 31 Count of miRNA genes: 29 Interacting mature miRNAs: 31 Transcripts: ENSRNOT00000066731 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549909 Stresp11 Stress response QTL 11 6.83 0.0019 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 8 73473045 118473045 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 9590292 Uminl3 Urine mineral level QTL 3 3.62 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 8 71888757 116888757 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 738011 Anxrr9 Anxiety related response QTL 9 6.1 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 8 93535351 123900184 Rat 8693654 Alc32 Alcohol consumption QTL 32 2 0.755 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 8 88612425 107550209 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 738014 Anxrr15 Anxiety related response QTL 15 3.6 0.005 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 8 95718998 123900184 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 70513503 118219066 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 2313400 Anxrr25 Anxiety related response QTL 25 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 8 89265192 114019816 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 69349194 112783834 Rat 1358903 Bp252 Blood pressure QTL 252 7 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 93965141 123900184 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 8694446 Bw170 Body weight QTL 170 12.07 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 8 71888757 116888757 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 2300182 Bmd56 Bone mineral density QTL 56 5.4 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 95718998 123900184 Rat 2300181 Bmd55 Bone mineral density QTL 55 5.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 76468691 121468691 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat 1358893 Bp263 Blood pressure QTL 263 5.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 93965141 123900184 Rat 8694200 Abfw4 Abdominal fat weight QTL 4 9.07 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 8 71888757 116888757 Rat 8694392 Bw161 Body weight QTL 161 8.06 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 8 71888757 116888757 Rat 61437 Cia6 Collagen induced arthritis QTL 6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 8 82460758 122812818 Rat
D8Rat128
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 8 107,195,614 - 107,195,774 (+) Marker Load Pipeline mRatBN7.2 8 98,316,156 - 98,316,316 (+) MAPPER mRatBN7.2 Rnor_6.0 8 105,697,532 - 105,697,691 NCBI Rnor6.0 Rnor_5.0 8 105,141,903 - 105,142,062 UniSTS Rnor5.0 RGSC_v3.4 8 102,883,463 - 102,883,622 UniSTS RGSC3.4 RGSC_v3.4 8 102,883,462 - 102,883,622 RGD RGSC3.4 RGSC_v3.1 8 102,902,666 - 102,903,146 RGD Celera 8 97,741,865 - 97,742,024 UniSTS SHRSP x BN Map 8 60.6299 UniSTS SHRSP x BN Map 8 60.6299 RGD Cytogenetic Map 8 q31 UniSTS
D8Rat127
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 8 107,154,907 - 107,155,081 (+) Marker Load Pipeline mRatBN7.2 8 98,275,437 - 98,275,613 (+) MAPPER mRatBN7.2 Rnor_6.0 8 105,577,600 - 105,577,773 NCBI Rnor6.0 Rnor_5.0 8 105,021,971 - 105,022,144 UniSTS Rnor5.0 RGSC_v3.4 8 102,844,445 - 102,844,618 UniSTS RGSC3.4 RGSC_v3.4 8 102,844,444 - 102,844,618 RGD RGSC3.4 RGSC_v3.1 8 102,863,887 - 102,864,215 RGD Celera 8 97,708,158 - 97,708,331 UniSTS SHRSP x BN Map 8 60.6299 UniSTS SHRSP x BN Map 8 60.6299 RGD Cytogenetic Map 8 q31 UniSTS
D8Got157
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 8 106,909,397 - 106,909,617 (+) Marker Load Pipeline mRatBN7.2 8 98,029,909 - 98,030,129 (+) MAPPER mRatBN7.2 Rnor_6.0 8 105,332,083 - 105,332,302 NCBI Rnor6.0 Rnor_5.0 8 104,776,632 - 104,776,851 UniSTS Rnor5.0 RGSC_v3.4 8 102,338,935 - 102,339,155 RGD RGSC3.4 RGSC_v3.4 8 102,338,936 - 102,339,155 UniSTS RGSC3.4 RGSC_v3.1 8 102,358,391 - 102,358,610 RGD Celera 8 97,462,669 - 97,462,888 UniSTS RH 3.4 Map 8 1077.59 UniSTS RH 3.4 Map 8 1077.59 RGD RH 2.0 Map 8 859.9 RGD Cytogenetic Map 8 q31 UniSTS
BI301360
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 98,453,829 - 98,453,982 (+) MAPPER mRatBN7.2 Rnor_6.0 8 105,834,795 - 105,834,947 NCBI Rnor6.0 Rnor_5.0 8 105,278,991 - 105,279,143 UniSTS Rnor5.0 RGSC_v3.4 8 103,020,934 - 103,021,086 UniSTS RGSC3.4 Celera 8 97,879,580 - 97,879,732 UniSTS RH 3.4 Map 8 1051.29 UniSTS Cytogenetic Map 8 q31 UniSTS
BE097605
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 98,024,570 - 98,024,726 (+) MAPPER mRatBN7.2 Rnor_6.0 8 105,326,742 - 105,326,897 NCBI Rnor6.0 Rnor_5.0 8 104,771,291 - 104,771,446 UniSTS Rnor5.0 RGSC_v3.4 8 102,344,344 - 102,344,499 UniSTS RGSC3.4 Celera 8 97,457,330 - 97,457,485 UniSTS RH 3.4 Map 8 1080.3 UniSTS Cytogenetic Map 8 q31 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
65
64
35
22
35
6
191
94
93
45
60
29
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000066731 ⟹ ENSRNOP00000060748
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 98,021,666 - 98,637,731 (-) Ensembl Rnor_6.0 Ensembl 8 105,323,859 - 105,462,141 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000078760 ⟹ ENSRNOP00000070212
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 98,021,666 - 98,160,567 (-) Ensembl Rnor_6.0 Ensembl 8 105,323,837 - 105,462,168 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000118831 ⟹ ENSRNOP00000077209
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 98,029,699 - 98,637,731 (-) Ensembl
RefSeq Acc Id:
NM_134377 ⟹ NP_599204
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 106,899,894 - 107,516,402 (-) NCBI mRatBN7.2 8 98,020,406 - 98,637,001 (-) NCBI Rnor_6.0 8 105,323,837 - 106,036,695 (-) NCBI Rnor_5.0 8 104,768,386 - 104,906,597 (-) NCBI RGSC_v3.4 8 102,614,117 - 103,214,037 (-) RGD Celera 8 97,454,425 - 98,063,036 (-) RGD
Sequence:
ATGCTGCCGGGGAGGCTGTGCTTGGTGCCGCTCCTGCTGGCGCTGGGCGTAGGGAGCGGCGGAGGCAGCGGCGACGGCGGGGACAGCCGGCGGCGCCGCCTCCTCGCGGCGAAAGTCAATAAACACAA GCCATGGATCGAGACATCGTATCATGGAGTCATAACTGAGAACAATGACACAGTCATCTTGGACCCTACTATCGTAGCCCTGGACAAAGACGCCCCAGTGCCATTTGCAGGGGAAATCTGCGCATTCA AGATCCATGGGCAGGAGCTGCCTTTTGAAGCTGTGGTGCTCAATAAGACATCTGGAGAGGGCCGGCTCCGTGCCAAGAGTCCCATCGACTGTGAGCTACAGAAGGAGTACACATTCATCATCCAGGCC TATGACTGTGGTGCAGGACCTCAGGAAGCAGCCTGGAAGAAGTCACACAAGGCTGTGGTCCACATCCAGGTGAAGGATGTCAATGAGTTCGCACCCACCTTCAAAGAACCAGCCTACAAAGCCATCGT CACAGAGGGCAAGATCTATGACAGCATCCTGCAGGTAGAAGCCATCGATGAGGACTGCTCCCCCCAATACAGCCAGATTTGCAACTATGAAATTGTCACGACGGATGTGCCTTTTGCCATTGACAGAA ATGGCAACATCAGAAACACTGAGAAGCTGAGCTATGACAAGCAACGCCAGTATGAGATCCTGGTAACTGCTTATGACTGTGGACAGAAGCCCGCTGCTCAGGACACCCTGGTCCAGGTGGATGTGAAG CCAGTGTGTAAGCCTGGCTGGCAAGATTGGACCAAAAGGATTGAGTACCAGCCCGGCTCAGGGAGTATGCCCTTGTTCCCCGGCATCCACCTGGAGACATGCGACGGAGCTGTGTCCTCCCTCCAGGT CACTGCAGAGCTGCAGACTAATTACATCGGCAAGGGCTGTGACCGAGAGACCTACTCTGAGAAATCCCTTCAGAAACTATGTGGAGCATCCTCGGGCATCATCGACCTCTTGCCATCCCCTAGTGCGG CTACCAACTGGACTGCTGGACTCCTGGTGGACAGCAGTGAGATGATCTTCAAGTTTGATGGCAGGCAGGGTGCCAAGATCCCAGATGGGATTGTGCCCAAGAACCTGACAGACCAGTTCACCATCACA ATGTGGATGAAACATGGCCCCAGCCCTGGCGTGAGAGCTGAGAAGGAAACCATCCTCTGTAACTCAGATAAAACTGAAATGAACCGGCATCACTATGCCTTGTATGTGCACAACTGCCGCCTTGTCTT CCTCCTGCGGAAGGACTTTGACCAGGCAGACACCTTTCGCCCCGCAGAGTTTCACTGGAAGCTGGACCAGATTTGTGACAAAGAGTGGCATTACTATGTCATCAATGTGGAGTTCCCTGTGGTCACCT TGTACATGGATGGAGCAACATATGAACCATACCTGGTGACCAATGACTGGCCCATTCATCCATCTCACATAGCCATGCAACTCACTGTCGGCGCCTGTTGGCAAGGAGGTGAAGTGGCCAAACCACGG TTTGCACAATTTTTCCATGGCAGCCTTGCCAGTCTCACAATCCGTCCTGGCAAAATGGAAAGCCAGAAGGTGATTTCTTGTTTGCAGGCCTGCAAAGAAGGGCTGGATATTAATTCCTTGGAAAGCCT TGGCCGAGGGATAAAGTATCACTTCAACCCTTCACAGTCCATCCTTGTGATGGAAGGCGATGACATTGGGAACATCAACCAAGCCCTCCAGAAAGTCTCCTACATCAACTCCAGGCAGTTCCCAACAG CAGGGGTCCGGCGCCTCAGACTCTCTTCTAAAGTCCAGTGCTTTGGGGAAGACGTGTGCATCAGCATCCCAGATGTGGATGCCTACATCATGGTCCTGCAGGCCATCGAGCCCCAGATCACCCTCCAG GGAACAGAGCGTTTCTGGAGACCTGCTGCCCAGTTCGAAAGTGCCAGAGGAGTGACTCTCTTCCCTGACATCAAGATCATCAGCACCTTTGCCAAGACTGAGGCCTCTGGGGACTTGAGAGCTACAGG CACAGCCCCCAAATCGGCAGTCTTGGAAGAAATGCTACATAATTTGGATTTCTGTGATATTTTGGTGCTTGGAGGGGACTTGGATCCAAGACAAGAGTGCTTGGAGCTCAACCACAGTGAGCTCCACC AACGACACCTTGATGCCACCAACTCTACTGCTGGCTACTCTATCTATGGTGTGGGGTCCATGAGCCGTTATGAGCAGGTACTGCACCACCTCCGTTACCGCAACTGGCACCCCACTTCCCTTGAGACT CGGAGGTTCCAGATCAAGTGTTCAGAGCTCAATGGGCGTTACACCAGCAATGAGTTCAACTTAGAGGTCAGTGTCCTCCATGAAGTTAGAGTCTCTGATACGGAACATGTCAACCATCTTATTGTGCA GCCACCCTTCCTCCAGTCTGTCTATCACCCTGAGACCCGGAGTAGTATCCAGCGCAGTTCAGTGGTCCCGAGCATCGCCACTGTGGTCATCATTATCTCTGTGTGCATGCTAGTGTTTGTTGTGGCCA TGGGTGTGTACCGAGTCCGAATTGCCCACCAGCATTTTATCCAAGAGACTGAGGCTGCCAAGGAGGCTGAAATGGATTGGGATGACTCTGCACTGACTATCACAGTCAACCCTATGGAGAAACATGAA GGACCAGGGCATGGAGAAGACGAGACTGAAGGAGAGGAAGAAGAAGAAGCAGAGGAAGGCATGAGCTCCAGCAGCAGTGGCTCTGATGACAGTGAAGAGGAAGAAGAGGAAGGGATGGGCAGAGTCAG ACATGGGCAGAGTGGCACCAGCTCTCAACGCCCTGAAAGAAGTACCTGGAATACAGCAGGAGTCATAAACATTTGGAAGTGAAGCACCTAGCTTGTCCCTACTT
hide sequence
RefSeq Acc Id:
NP_599204 ⟸ NM_134377
- Peptide Label:
precursor
- UniProtKB:
Q8VDA1 (UniProtKB/Swiss-Prot), F1LMG0 (UniProtKB/TrEMBL), A6I2A5 (UniProtKB/TrEMBL)
- Sequence:
MLPGRLCLVPLLLALGVGSGGGSGDGGDSRRRRLLAAKVNKHKPWIETSYHGVITENNDTVILDPTIVALDKDAPVPFAGEICAFKIHGQELPFEAVVLNKTSGEGRLRAKSPIDCELQKEYTFIIQA YDCGAGPQEAAWKKSHKAVVHIQVKDVNEFAPTFKEPAYKAIVTEGKIYDSILQVEAIDEDCSPQYSQICNYEIVTTDVPFAIDRNGNIRNTEKLSYDKQRQYEILVTAYDCGQKPAAQDTLVQVDVK PVCKPGWQDWTKRIEYQPGSGSMPLFPGIHLETCDGAVSSLQVTAELQTNYIGKGCDRETYSEKSLQKLCGASSGIIDLLPSPSAATNWTAGLLVDSSEMIFKFDGRQGAKIPDGIVPKNLTDQFTIT MWMKHGPSPGVRAEKETILCNSDKTEMNRHHYALYVHNCRLVFLLRKDFDQADTFRPAEFHWKLDQICDKEWHYYVINVEFPVVTLYMDGATYEPYLVTNDWPIHPSHIAMQLTVGACWQGGEVAKPR FAQFFHGSLASLTIRPGKMESQKVISCLQACKEGLDINSLESLGRGIKYHFNPSQSILVMEGDDIGNINQALQKVSYINSRQFPTAGVRRLRLSSKVQCFGEDVCISIPDVDAYIMVLQAIEPQITLQ GTERFWRPAAQFESARGVTLFPDIKIISTFAKTEASGDLRATGTAPKSAVLEEMLHNLDFCDILVLGGDLDPRQECLELNHSELHQRHLDATNSTAGYSIYGVGSMSRYEQVLHHLRYRNWHPTSLET RRFQIKCSELNGRYTSNEFNLEVSVLHEVRVSDTEHVNHLIVQPPFLQSVYHPETRSSIQRSSVVPSIATVVIIISVCMLVFVVAMGVYRVRIAHQHFIQETEAAKEAEMDWDDSALTITVNPMEKHE GPGHGEDETEGEEEEEAEEGMSSSSSGSDDSEEEEEEGMGRVRHGQSGTSSQRPERSTWNTAGVINIWK
hide sequence
Ensembl Acc Id:
ENSRNOP00000070212 ⟸ ENSRNOT00000078760
Ensembl Acc Id:
ENSRNOP00000060748 ⟸ ENSRNOT00000066731
Ensembl Acc Id:
ENSRNOP00000077209 ⟸ ENSRNOT00000118831
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-04-17
Clstn2
calsyntenin 2
LOC100359585
calsyntenin 2
Data merged from RGD:2323609
737654
PROVISIONAL
2010-05-06
LOC100359585
calsyntenin 2
Symbol and Name status set to provisional
70820
PROVISIONAL
2005-01-20
Clstn2
calsyntenin 2
Cstn2
Symbol updated
1299863
APPROVED
2002-08-07
Cstn2
calsyntenin 2
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_expression
expressed in excitatory central nervous system (CNS) synapses
632523